DR REDDYS LABORATORIES
Back to Income Statement
|
DR REDDYS LABORATORIES Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹24,670 Cr | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr | ₹15,448 Cr |
What is the latest Revenue of DR REDDYS LABORATORIES ?
Year | Revenue |
---|---|
Mar2024 | ₹24,670 Cr |
Mar2023 | ₹21,545 Cr |
Mar2022 | ₹19,048 Cr |
Mar2021 | ₹17,517 Cr |
Mar2020 | ₹15,448 Cr |
How is Revenue of DR REDDYS LABORATORIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹24,670 Cr | 14.50 | |
Mar2023 | ₹21,545 Cr | 13.11 | |
Mar2022 | ₹19,048 Cr | 8.74 | |
Mar2021 | ₹17,517 Cr | 13.39 | |
Mar2020 | ₹15,448 Cr | - |
Compare Revenue of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹98,613.6 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
MANKIND PHARMA | ₹102,232.0 Cr | -5.9% | -14% | 21% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -8.3% |
-14.9% |
0.8% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses